what is glp-1 drugs for weight loss Comparing Ozempic, Wegovy and Other Understanding GLP Drugs: What They

For people who were on statins before starting semaglutide, the combined effect of the statin and semaglutide-mediated fat loss can sometimes move lipid markers significantly

In large-scale studies, semaglutide (the active ingredient in Ozempic and Wegovy) led to an average placebo-corrected weight loss of about 12.4% at the 2.4 mg dose

Finding the right approach often requires personalized medical guidance

however, EMS personnel need to be alert for the use of counterfeited drug as well

This has prompted investigation into higher-potency GLP-1RAs and monotherapy approaches, including dual incretin agents such as tirzepatide, to assess whether stronger metabolic effects can be achieved in this age group

These CVOT findings are supported by a real-world study performed in over 3 million patients with T2DM from the United States, in which patients treated with SGLT2is did not have a higher risk of any or lower amputation compared with incretins or other glucose-lowering agents [77]